Prevalence of Risk Factors for Cardiovascular Disease among Hypertensive Patients in Primary Care Unit in Nakhon Si Thammarat
ความชุกของปัจจัยเสี่ยงต่อการเกิดโรคหัวใจ และหลอดเลือด ของผู้ที่มีความดันโลหิตสูงในสถานบริการปฐมภูมิ จังหวัดนครศรีธรรมราช
Keywords:
Prevalence, Risk factors for cardiovascular disease, Hypertension, Secondary dataAbstract
ABSTRACT
Descriptive research aimed to study the prevalence of risk factors for cardiovascular disease among 302 hypertensive patients in one health-promoting hospital in Nakhon Si Thammarat. The secondary data from medical records taken one year ago were analyzed. Data were analyzed by using the Chi-squared test and the crude odds ratio (OR) at 95% confidential interval (95%CI). The study found that the prevalence of risk factors for cardiovascular disease, which was classified by gender and by weighting the influence of the Global Risk Assessment Scoring, was a significant difference between male and female. High prevalence of risk factors in female were diabetes and high cholesterol while systolic blood pressure and smoking were found in males. The sample with the high-risk level was 42.0 %, the moderate risk was 52.0 % and, low risk was 6.0%. It showed that 81.1% of males had a high-risk level, whereas the figure was 25.5% for females. The major factors of high risk for cardiovascular disease were age and smoking in male, male aged >60 years old had 7.6 times with a high-risk group compared to the younger group and a smoker had five times more likely with a high-risk group than a nonsmoker. In female with diabetes, there was a high risk for cardiovascular disease, 4.4 times more than non-diabetes and, one with triglyceride ≥150 mg/dl had doubled higher risk than one with normal triglyceride level. This study demonstrated that the prevalence of cardiovascular risk factors is different between males and females. Therefore, the plan for preventive activities should be specific and relevant to the prevalence of risk factors by gender.
References
1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and
stroke statistics—2017 update: a report from the American Heart
Association.Circulation. 2017; 135:e146–603.
2. International Health Policy Program-Thailand: The study of burden of diseases in
Thai population in 2014. Nontabury: The Graphico systems co.,ltd.; 2017. (in Thai)
3. D'Agostino R, Pencina M, Massaro J, Coady S. Cardiovascular Disease Risk Assessment:
Insights from Framingham. Global Heart. 2013;8(1):11-23.
4. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640–1645.
5.Karmali KN, Lloyd-Jones DM. Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention. Hypertension. 2017;69(3): e2–e9.
6. Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: A report of the American College of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiology.2014; 63: 2935-59.
7.Alshehri AM. Metabolic syndrome and cardiovascular risk. J Family Community Med.2010;17(2):73–78.
8. Bitton A, Gaziano TA. The Framingham Heart Study's impact on global risk assessment.
Prog Cardiovasc Dis. 2010;53(1):68–78.
9. Yip W, Wong TY, Jonas JB, et al. Prevalence, awareness, and control of hypertension among Asian Indians living in urban Singapore and rural India. J Hypertens 2013;31:1539–46.
10.Liew SJ, Lee JT, Tan CS, et al. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multiethnic Asian population: a crosssectional study. BMJ .2019; 9:e025869.
11. Wu J, Li T, Song X, et al. Prevalence and distribution of hypertension and related risk factors in Jilin Province, China 2015: a cross-sectional study. BMJ Open. 2018;8(3): e020126.
12. Weycker D, Nichols G, Okeefferosetti M, Edelsberg J, Khan Z, Kaura S, et al. Risk-Factor
Clustering and Cardiovascular Disease Risk in Hypertensive Patients. American Journal
of Hypertension. 2007;20(6):599-607.
13. Keto J, Ventola H, Jokelainen J, et al. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016;3(2): e000358.
14. Ukena, C., Mahfoud, F., Kindermann, M., Graber, S., Kindermann, I., Schneider, M.,… Bohm, M. Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: Data from I-SEARCH. Clinical Research in Cardiology.2010; 99(12): 825-832.
15. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation 2005; Brussels: Belgium.
16. Sallam T, Watson KE. Predictors of cardiovascular risk in women. Womens Health (Lond). 2013;9(5):491-8.
